These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 32666928

  • 1. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
    Didona D, Juratli HA, Scarsella L, Keber U, Eming R, Hertl M.
    Eur J Dermatol; 2020 Jun 01; 30(3):279-288. PubMed ID: 32666928
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
    Ueda-Hayakawa I, Hamaguchi Y, Okiyama N, Motegi S, Yamaoka T, Miyake S, Higashi A, Okamoto H, Takehara K, Fujimoto M.
    Br J Dermatol; 2019 Apr 01; 180(4):881-887. PubMed ID: 30120913
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA.
    Folia Med (Plovdiv); 2017 Mar 01; 59(1):7-13. PubMed ID: 28384112
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.
    Tymms KE, Beller EM, Webb J, Schrieber L, Buchanan WW.
    Clin Rheumatol; 1990 Dec 01; 9(4):523-9. PubMed ID: 2088650
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis.
    Ikeda N, Yamaguchi Y, Kanaoka M, Ototake Y, Akita A, Watanabe T, Aihara M.
    J Dermatol; 2020 May 01; 47(5):490-496. PubMed ID: 32103537
    [Abstract] [Full Text] [Related]

  • 9. Amyopathic dermatomyositis.
    Saoud B, Allali F, Hassouni NH.
    Joint Bone Spine; 2006 May 01; 73(3):318-20. PubMed ID: 16253536
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ, Li YH, Zhang LH, Ma L, He WW, Jin YB, An Y, Li ZG, Ye H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec 18; 52(6):1001-1008. PubMed ID: 33331305
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G, Clapasson A, Cozzani E, Sanna L, Pesce G, Bagnasco M, Burlando M, Parodi A.
    Arch Dermatol Res; 2017 Mar 18; 309(2):87-95. PubMed ID: 27928683
    [Abstract] [Full Text] [Related]

  • 14. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y, Fu Q, Wang R, Guo Q, Bao C.
    J Clin Lab Anal; 2019 Oct 18; 33(8):e22978. PubMed ID: 31301087
    [Abstract] [Full Text] [Related]

  • 15. Amyopathic dermatomyositis.
    Olsen NJ, Park JH, King LE.
    Curr Rheumatol Rep; 2001 Aug 18; 3(4):346-51. PubMed ID: 11470054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.